{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:05:56Z","timestamp":1784289956971,"version":"3.55.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaad.2026.02.121","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T07:43:59Z","timestamp":1772696639000},"page":"e105-e106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ethics of insurance-driven barriers to biologic therapy in hidradenitis suppurativa"],"prefix":"10.1016","volume":"95","author":[{"given":"Esther O.","family":"Nwozo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiebuka","family":"Onuoha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Negbenebor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaad.2026.02.121_bib1","article-title":"Barriers and facilitators to quality HS biologic care and outcomes for the Medicaid population across US states","volume":"8","year":"2024","journal-title":"J Skin"},{"issue":"3","key":"10.1016\/j.jaad.2026.02.121_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2340\/00015555-1082","article-title":"Psychosocial impact of hidradenitis suppurativa: a qualitative study","volume":"91","author":"Esmann","year":"2011","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2026.02.121_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2340\/00015555-2129","article-title":"Disutility in patients with hidradenitis suppurativa: a cross-sectional study using EuroQoL-5D","volume":"96","author":"Riis","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"10.1016\/j.jaad.2026.02.121_bib4","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1007\/s13555-025-01496-x","article-title":"Exploring the experience of Black Americans living with hidradenitis suppurativa in the United States healthcare system: a narrative review","volume":"15","author":"Negbenebor","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"10.1016\/j.jaad.2026.02.121_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000509119","article-title":"Principles of clinical ethics and their application to practice","volume":"30","author":"Varkey","year":"2021","journal-title":"Med Princ Pract"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226003555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226003555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:39:27Z","timestamp":1784288367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226003555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0190962226003555"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.02.121","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethics of insurance-driven barriers to biologic therapy in hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.02.121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}